As of July 19, 2025, GW Pharmaceuticals PLC (GWPRF) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing GW Pharmaceuticals PLC's Forward P/E to Peers
To better understand GW Pharmaceuticals PLC's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| GW Pharmaceuticals PLC (GWPRF) | - |
| Dechra Pharmaceuticals PLC (DPH.L) | 3009.20 |
| AstraZeneca PLC (AZN.L) | 1583.17 |
| Alliance Pharma PLC (APH.L) | 1272.23 |
| Hikma Pharmaceuticals PLC (HIK.L) | 1152.11 |
| Indivior PLC (INDV.L) | 1141.34 |
Compared to its competitors, GW Pharmaceuticals PLC's Forward P/E is difficult to compare due to insufficient data.